Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas
Laura Remacha(Spanish National Cancer Research Centre), Alberto Cascón(Spanish National Cancer Research Centre), Miguel Urioste(Instituto de Salud Carlos III), Emiliano Honrado(Spanish National Cancer Research Centre), María Currás-Freixes(Spanish National Cancer Research Centre), Raúl M. Luque(Instituto de Salud Carlos III), Guillermo Pita(Spanish National Cancer Research Centre), Marcos Lahera(Hospital Universitario de La Princesa), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Gromoslaw A. Smolen(Celsius Therapeutics (United States)), Christopher E. Mahoney(Agios Pharmaceuticals (United States)), Óscar García-Uriarte(Hospital Universitario Araba), Rafael Torres‐Pérez(Spanish National Cancer Research Centre), David Pirman(Pfizer (United States)), Cristina Moreno-Rengel(Hospital de Basurto), Javier Aller(Hospital Universitario Puerta de Hierro Majadahonda), Bruna Calsina(Spanish National Cancer Research Centre), Óscar Llorca(Spanish National Cancer Research Centre), Belén Herráez(Spanish National Cancer Research Centre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Giovanni Cianchetta(Agios Pharmaceuticals (United States)), Javier Pardo de Santayana y Coloma(Spanish National Cancer Research Centre), Cristina Montero‐Conde(Spanish National Cancer Research Centre), Susan Richter(University of Auckland), Lorena Maestre(Spanish National Cancer Research Centre), María A. Gálvez(Hospital Universitario Reina Sofía), Rocío Letón
Cited by 22
Related Papers
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
|Nature Genetics|2013|544
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations
|Cancer Discovery|2017|457
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
|Journal of Hypertension|2020|406
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
|Human Molecular Genetics|2013|394